Miltenyi Biotec
Miltenyi Biotec is a global biotechnology company that develops and manufactures products and services for cell separation, cell therapy, flow cytometry, and related research and clinical applications. It serves academic and industrial researchers, biopharmaceutical companies, and clinical institutions with instruments, reagents, and contract services that support basic research, drug development, and cell and gene therapy manufacturing. Revenue is generated primarily through the sale of lab equipment and consumables, as well as specialized services and solutions for cell processing and analysis.
- Revenue
- $900.0M
- Employees
- 5,000
- Founded
- 1989
- Headquarters
- Bergisch Gladbach, Germany
What 11 Arbolus experts think of Miltenyi Biotec
The NPS distribution shows three 10 scores, one 7, and one 6, indicating a customer sentiment profile skewed towards high satisfaction, especially among Users and Influencers with >1 year implementation. Renewal intent is positive (Yes) for two Influencers and uncertain for one at early stage, mapping closely to implementation maturity. Implementations are mostly >1 year, with one early-stage User and one early-stage Influencer. The key quantitative themes are strong loyalty and satisfaction during mature implementation stages and rising sentiment as integration increases.Overall Customer Sentiment: Positive
Who reviewed Miltenyi Biotec
- C-Suite 60% (7)
- Director 20% (2)
- Manager 20% (2)
Employer names and spend open once the report publishes.
Tell us when the Miltenyi Biotec report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
54 Net Promoter Score, from 11 scored reviews- Promoters 8
- Passives 1
- Detractors 2
Cumulative NPS by month
-2 over 6 months- Jun 10
- Jan 9
- May 8
- Jun 9
- Sep 8
- Oct 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 54 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 75%Plan to renew, by seniority
- 100% 1 answer
- 100% 2 answers
- 0% 1 answer
- 8.7/10 Average score from customers who will renew
- 6/10 Average score from undecided customers
For people who use Miltenyi Biotec
Do you use Miltenyi Biotec at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 11 customers of Miltenyi Biotec have already contributed
Takes a few minutes. Your identity stays anonymous.